A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine.
Kana YamamotoTakahisa MashibaKeisuke TakanoToshihiko SuzukiMasahiro KamiMorihito TakitaEiji KusumiYasuhiro MizunoTamae HamakiPublished in: Vaccines (2021)
COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination.
Keyphrases
- coronavirus disease
- sars cov
- case report
- heart failure
- atrial fibrillation
- chronic obstructive pulmonary disease
- respiratory syndrome coronavirus
- healthcare
- left ventricular
- intensive care unit
- risk factors
- coronary artery disease
- left atrial
- percutaneous coronary intervention
- binding protein
- health information
- acute heart failure
- direct oral anticoagulants
- acute respiratory distress syndrome
- cardiac resynchronization therapy